2024
Mood lability and depression limit oral contraceptive therapy in endometriosis
Cevik E, Taylor H. Mood lability and depression limit oral contraceptive therapy in endometriosis. Fertility And Sterility 2024, 123: 838-845. PMID: 39672361, DOI: 10.1016/j.fertnstert.2024.12.011.Peer-Reviewed Original ResearchProgestin-only oral contraceptivesOral contraceptivesOC discontinuationOC useDiagnosis of depressionMood labilityEffects of oral contraceptivesOral contraceptive (OCDocumented diagnosis of depressionDiscontinued OC useEffect of OC useInternational Classification of Diseases-10 codesSide effects of OC useElectronic medical record reviewTreated with OCCourse of treatmentMedical record reviewIncreased incidence of depressionUniversity affiliated hospitalTreatment discontinuationIncidence of depressionEndometriosisStudy cohortPrimary outcomeIncreased incidence
2021
81. Medical management of endometriosis in adolescent women: a review of 91 cases of biopsy-confirmed endometriosis
Li H, Cho Y, Taylor H, Vash-Margita A. 81. Medical management of endometriosis in adolescent women: a review of 91 cases of biopsy-confirmed endometriosis. Journal Of Pediatric And Adolescent Gynecology 2021, 34: 271-272. DOI: 10.1016/j.jpag.2021.02.085.Peer-Reviewed Original ResearchBiopsy-proven endometriosisOral contraceptivesLNG-IUDOral progestinCurrent treatmentYounger patientsInitial treatmentRetrospective medical record reviewCurrent hormonal treatmentsTertiary hospital systemICD-9/10 codesCommon initial treatmentMedical record reviewReproductive-aged womenCommon treatment modalityInstitutional review boardYoung adult femalesPelvic painEndometriosis treatmentInitial presentationOptimal regimensBackground EndometriosisMedical managementRecord reviewTreatment course
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply